IONICSCALE LLC
ATLANTA, GA · Medtech · Private
Chip-scale ion trap mass analyzer for compact, portable mass spectrometers
ionicscale.com →- Grants
- $1.4M
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $166K
- 1 award · Homeland Security
- #474 of 4531 in medtech
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓202220232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | National Science Foundation · Phase I · SBIR Phase I:Low cost, portable mass spectrometers based on a chip-scale ion trap mass analyzer | $256,000 | |
| Federal grant | Department of Agriculture · With The Growing Demand For Effective, Yet Socially And Environmentally Conscious Solutions To Our Fundamental Agricultural Supply Chains, The Need For Widely Deployable Sensing Instruments To Detect And Monitor Chemical Signatures Of Contamination, Infestation, Or Other Potential Issues Is Critically Needed. Ionicscale Llc Is Developing Low-cost, Compact Mass Spectrometry-based Chemical Sensors That Can Be Utilized For This Purpose, Among Many Others.this Phase I Project Will Enable Substantial | $175,000 | |
| Federal grant | National Science Foundation · Phase II · SBIR Phase II: An ultra-compact, remotely programmable chemical analyzer utilizing a novel ion trap mass spectrometer | $1,000,000 | |
| Federal contract | Department of Homeland Security · New Contract For SBIR Phase I Topic 1: DHS241-001 Agnostic Detection Of Synthetic Opioids And Other Illicit Drugs. | $166,089 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 471 | Assurex Health | $171K | — |
| 472 | Gold Standard Diagnostics Corp. | $167K | $2.5M |
| 473 | CMP Scientific Corp | $167K | $300K |
| 474 | IONICSCALE LLC | $166K | — |
| 475 | GPB Scientific, Inc. | $164K | $41M |
| 476 | iRhythm Technologies, Inc. | $163K | $59M |
| 477 | Coalesenz Inc. | $163K | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.